Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06420557 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement

Study acronym: DecNef
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Sep 30, 2026 → Mar 30, 2027
See other at-risk trials from University of California, Los Angeles

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Sep 30, 2026 to Mar 30, 2027
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 7 of 10 entries
  2. Minor Site contact updated
    • Collaborators expanded, about 6 words
    v5
  3. Minor Start date changed from estimate of Aug 2024 to Sep 9, 2024
    • Site contact updated
    v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jul 1, 2024 to Aug 2024
    • Secondary endpoints: 7 to 10
    • Site details revised
    v3
  5. Notable Start date: Jun 1, 2024 to Jul 1, 2024
    • Secondary endpoints: details revised at 2 of 7 entries
    • Eligibility criteria expanded, about 4 words
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This application investigates the efficacy of a novel method of neuro-reinforcement based on decoded fMRI activity to reduce fear responses in individuals with phobias (e.g., spiders, snakes). This method works unconsciously in the brain, without the need for participants to endure repeated conscious exposures to their feared stimuli. Fear-related disorders such as specific phobia, post-traumatic stress disorder (PTSD), and other anxiety disorders present a major challenge, as effective treatment options usually involve repeated exposures to feared stimuli, leading to high levels of distress, fear, and panic that can motivate premature treatment termination. Consequently, there is an unmet need for treatment that minimizes subjective discomfort and attrition in order to maximize efficacy. Recent developments in computational neuroimaging have enabled a method that can deliver unconscious exposure to feared stimuli, resulting in effective fear reduction while bypassing a primary cause of treatment attrition. Because this treatment method happens unconsciously in the brain, changes in behavior outcomes are potentially more likely to generalize to different contexts, thereby overcoming a limitation of traditional treatments.
Trial Details
NCT Number NCT06420557
Lead Sponsor University of California, Los Angeles
Collaborators: National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Phobia
Related terms Anxiety Disorders, Phobic Disorders
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov